AtriCure, Inc. (NASDAQ: ATRC) today announced that it has appointed Pacific Medical Systems Ltd., as its exclusive distributor for all AtriCure products in Hong Kong, Macau, Taiwan and South East Asia.

Jon Hoem, Managing Director Europe and Asia of AtriCure said "We are confident that our appointment of Pacific Medical Systems will enable us to gain rapid market access and ability to replicate the successes AtriCure enjoys in Europe and the US, where AtriCure has the leading market shares in both open chest and closed chest management of AF. Pacific Medical Systems is a team of highly skilled and dedicated professionals, with in-depth product and clinical knowledge, solid customer relationships and has an effective distribution network in Asia. We are excited to partner with Pacific Medical Systems and excel AtriCure’s position in Asia”.

Jules Flach, Founder and CEO of Pacific Medical Systems said “There is a tremendous interest in the technology offered by AtriCure for the management of AF. Many surgeons have learned about the advanced bipolar / transpolar clamps with dedicated designs for both open and closed chest procedures through their overseas training and/or presentations in academic meetings on the advanced clinical and research work on management of AF with AtriCure. Its novel and most easy to use RF Ablation generator shows the surgeon when Transmurality is achieved, taking away the guesswork and provide confirmation of a successful conduction block. We are thrilled to be representing AtriCure in this part of the world, and we are very confident AtriCure will become the dominant player in AF Surgery in Asia.”